Clinical Evaluation of Soft Tissue Esthetics Around Immediate Implant Using Dual Zone Therapeutic Concept Versus Buccal Gap Fill to Bone Level

December 5, 2018 updated by: RWGWanis, Cairo University

Clinical Evaluation of Soft Tissue Esthetics Around Immediate Implant Using Dual Zone Therapeutic Concept Versus Buccal Gap Fill to Bone Level.A Randomized Controlled Clinical Trial

Immediate implant placement in the esthetic zone is very challenging procedure although it is documented as a promising procedure (Berglundh, Persson and Klinge, 2002)(Cosyn et al., 2011). Extraction is usually accompanied by remodeling of the hard tissues which is more crucial in the anterior maxilla as it affects soft tissue esthetics(Araujo and Lindhe, 2005)(Covani et al., 2004)(Juodzbalys and Wang, 2007). It is well established that implant placement without filling the buccal gap leads to noticeable amount of bone loss at the alveolar contour(Botticelli, Berglundh and Lindhe, 2004)(Sanz et al., 2010). The protocol of immediate implant and temporization serves to provide acceptable esthetic results but soft tissue stability around the implant restoration is not always satisfactory(Noelken et al., 2018).Amount of soft tissue recession can be specified following immediate implant placement, even with flapless technique there is a limited risk of midfacial recession(Cosyn, Hooghe and De Bruyn, 2012).It was found that inadequate bone grafting in the facial defect increases the chance of mid facial recession(Le, Borzabadi-Farahani and Pluemsakunthai, 2014).

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

By definition, the dual zone can be divided into soft tissue zone and bone zone; the soft tissue zone is the vertical dimension change measured from the free gingival margin to the mid crest labially, the bone zone is the hard tissues measured from the crestal bone towards the apex(Chu et al., 2012). The concept of the dual zone aims to maintain the hard, soft tissue volume and the blood clot where the grafting material act as a scaffold containing them and this will enhance the initial healing compared to the classic protocol of bone filling till the buccal bone level(Chu et al., 2012). A recent study claims that the xenograft particles can be successfully incorporated within the soft tissue without inflammation enhancing the soft tissue profile(Araujo and Lindhe, 2005). The temporary restoration has shown socket sealing property which protect and contain the blood clot and the graft material enhancing healing,thus filling the gap without involvement of the soft tissue has been the rational for immediate implant placement(Trimpou G, Weigl P, Krebs M, 2010).The main benefit of the dual zone concept is maintaining the blood supply from the periosteum and endosteum producing maximum healing potential with preserving the soft tissue stability by filling the soft tissue zone with bone graft in addition to immediate temporization acting as socket seal(Chu et al., 2012).

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients who have at least one non restorable tooth in the esthetic zone that needs to be extracted.
  2. Patients with healthy systemic condition.(Brightman. 1994)
  3. Patients aged from 20 to 45 years old.
  4. Buccal bone thickness should be at least 1mm. (Morton et al., 2014)
  5. Availability of bone apical and palatal to the socket to provide primary stability.(Morton et al., 2014)
  6. Good oral hygiene.(Wiesner et al., 2010)
  7. Accepts one year follow-up period (cooperative patients).
  8. Patient provides an informed consent.
  9. Adequate Inter-arch space for implant placement.
  10. favorable occlusion (no traumatic occlusion)

Exclusion Criteria:

  1. Patients with signs of acute infection related to the area of interest.
  2. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al., 2006).
  3. Current and former smokers (Lambert, Morris and Ochi, 2000)
  4. Pregnant females.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: immediate implant with dual zone therapeutic concept
immediate implant with bone fill till soft tissue level
ACTIVE_COMPARATOR: immediate implant with buccal bone fill
immediate implant with bone fill till soft tissue level

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pink Esthetic Score
Time Frame: 12 months post surgery
The PES is based on seven variables: mesial papilla, distal papilla, soft-tissue level, softtissuecontour, alveolar process deficiency,soft-tissue color and texture. Each variable shall be assessed with a 2-1-0 score,with 2 being the best and 0 being thepoorest score.The mesial and distal papilla will be evaluatedfor completeness, incompleteness orabsence. All other variables will be assessedby comparison to a reference tooth.(Fürhauser et al., 2005)
12 months post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Buccal bone thickness
Time Frame: 12 months post surgery
using a specially designed device that will be screwed to the fixture. (Merheb et al., 2016)
12 months post surgery
Gingival Thickness
Time Frame: 12 months post surgery
Will be measured using an anesthetic needle with a rubber stopper,transgingivally piercing tissues horizontally,perpendicular to the long axis of the tooth/implant until it contacts bone, at 9 different points; three readings: mesially, midbuccally and distally at three different levels; 2mm, 4mm and 6mm apical to the gingival margin.The lengthof the part of the instrument that penetratedinto the soft tissue is measured in mm.(Wiesner et al., 2010)
12 months post surgery
Keratinized tissue width
Time Frame: 12 months post surgery
Will be measured by a periodontal probe from the gingival margin to the mucogingival junction, at the mid buccal area.
12 months post surgery
Post operative swelling
Time Frame: 12 months post surgery
Verbal Rating Scale (VRS); absent(no swelling), slight (intraoral swelling at the operated area), moderate (moderate intraoral swelling at the operated area) and intense (intensive extraoral swelling extending beyond the operated area), assessed during the first 7 postoperative days. (García et al., 2008)
12 months post surgery
Post Surgical Patient Satisfaction: Questionnaire
Time Frame: 12 months post surgery
A 3-item questionnaire is asked and the patients shall use a 7 point answer scale. (Kiyak et al., 1984)
12 months post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 20, 2018

Primary Completion (ANTICIPATED)

November 20, 2019

Study Completion (ANTICIPATED)

November 20, 2020

Study Registration Dates

First Submitted

December 3, 2018

First Submitted That Met QC Criteria

December 5, 2018

First Posted (ACTUAL)

December 7, 2018

Study Record Updates

Last Update Posted (ACTUAL)

December 7, 2018

Last Update Submitted That Met QC Criteria

December 5, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2508

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Immediate Implant and Bone Graft

Clinical Trials on dual zone concept

3
Subscribe